Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 26818M108 since 12/18/2024, largest first.
| Filer | % of Class | Filed | ||
|---|---|---|---|---|
| T. Rowe Price Investment Management, Inc. 13G/A | 18.7% |
5/15/2026
Event 3/31/2026
|
||
| Janus Henderson Group Ltd. 13G/A | 7.3% |
8/13/2026
Event 6/30/2026
|
||
| BlackRock, Inc. 13G/A | 7.0% |
7/28/2026
Event 6/30/2026
|
||
|
FMR LLC
13G/A
|
6.8% |
8/6/2026
Event 6/30/2026
|
||
| FMR LLC | 6.8% | |||
| Abigail P. Johnson | 6.8% | |||
| Under 5%, checked the "5 percent or less" box, or amended by a later filing (6) | ||||
|
Forbion Capital Fund IV Cooperatief U.A.
13G/A
|
4.8% |
5/15/2025
Event 3/31/2025
|
||
| ForDyne B.V. | 4.8% | |||
| Forbion Capital Fund IV Cooperatief U.A. | 3.6% | |||
| Forbion IV Management B.V. | 3.6% | |||
| Forbion Growth Opportunities Fund II Cooperatief U.A. | 1.3% | |||
| Forbion Growth II Management B.V. | 1.3% | |||
|
Atlas Venture Fund XI, L.P.
13G/A
|
2.4% |
8/13/2026
Event 6/30/2026
|
||
| Atlas Venture Fund XI, L.P. | 2.4% | |||
| Atlas Venture Associates XI, L.P. | 2.4% | |||
| Atlas Venture Associates XI, LLC | 2.4% | |||
| Atlas Venture Opportunity Fund I, L.P. | 0.5% | |||
| Atlas Venture Associates Opportunity I, L.P. | 0.5% | |||
| Atlas Venture Associates Opportunity I, LLC | 0.5% | |||
| Atlas Venture Opportunity Fund II, L.P. | 0.7% | |||
| Atlas Venture Associates Opportunity II, L.P. | 0.7% | |||
| Atlas Venture Associates Opportunity II, LLC | 0.7% | |||
|
RTW Investments, LP
13G/A
|
1.5% |
5/15/2025
Event 3/31/2025
|
||
| RTW Investments, LP | 1.5% | |||
| Roderick Wong, M.D. | 1.5% | |||
|
Point72 Asset Management, L.P.
13G/A
|
1.5% |
5/15/2025
Event 3/31/2025
|
||
| Point72 Asset Management, L.P. | 1.5% | |||
| Point72 Capital Advisors, Inc. | 1.5% | |||
| Steven A. Cohen | 1.5% | |||
|
RA Capital Management, L.P.
13G/A
|
0% |
11/14/2025
Event 9/30/2025
|
||
| RA Capital Management, L.P. | 0% | |||
| Peter Kolchinsky | 0% | |||
| Rajeev Shah | 0% | |||
| RA Capital Healthcare Fund, L.P. | 0% | |||
| Vanguard Group Inc 13G/A | 0% |
3/26/2026
Event 3/13/2026
|
||
| Period | Filings | Shares, Excl. Options | Value, Excl. Options |
|---|---|---|---|
| 2026 Q3 | 4 | 3.04 k | $48.9 k |
| 2026 Q2 | 255 | 194 M | $4.37 B |
| 2026 Q1 | 238 | 188 M | $3.41 B |
| 2025 Q4 | 245 | 181 M | $3.54 B |
| 2025 Q3 | 219 | 159 M | $2.01 B |
| 2025 Q2 | 205 | 129 M | $1.23 B |
| 2025 Q1 | 213 | 122 M | $1.29 B |
| 2024 Q4 | 209 | 112 M | $2.63 B |
| 2024 Q3 | 210 | 113 M | $4.04 B |
| 2024 Q2 | 204 | 113 M | $3.97 B |
| 2024 Q1 | 182 | 97.4 M | $2.76 B |
| 2023 Q4 | 142 | 74.3 M | $989 M |
| 2023 Q3 | 121 | 59.9 M | $537 M |
| 2023 Q2 | 122 | 59.2 M | $666 M |
| 2023 Q1 | 132 | 54.7 M | $629 M |
| 2022 Q4 | 118 | 50.3 M | $583 M |
| 2022 Q3 | 106 | 45.3 M | $576 M |
| 2022 Q2 | 91 | 46.7 M | $321 M |
| 2022 Q1 | 96 | 47.7 M | $457 M |
| 2021 Q4 | 95 | 47.8 M | $568 M |
| 2021 Q3 | 84 | 35.3 M | $573 M |
| 2021 Q2 | 77 | 35.8 M | $753 M |
| 2021 Q1 | 76 | 34.3 M | $533 M |
| 2020 Q4 | 70 | 29.3 M | $615 M |
| 2020 Q3 | 51 | 27.5 M | $554 M |